Jerusalem G, Delea TE, Martin M, De Laurentiis M, et al. Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR+/-HER2- Advanced Breast Cancer in the MONALEESA-3 Trial. Clin Breast Cancer 2021 Dec 20. pii: S1526-8209(21)00369.
PMID: 35034858